Rapport Therapeutics, a clinical-stage biotech company focused on precision medicines for neurological and psychiatric disorders, announced participation in two upcoming investor conferences: the Stifel 2026 Healthcare Conference in New York on November 11, and the Jefferies Global Healthcare Conference in London on November 16. Management will engage in presentations and fireside chats, with live webcasts available on the company's website. This exposure aims to update investors on their lead drug candidate RAP-219 and other pipeline developments targeting epilepsy, bipolar mania, chronic pain, migraine, and hearing disorders.
Rapport Therapeutics' upcoming investor conferences provide context for Pluang's health sector data. For readers following health stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: Out of 150 priced health-sector US stocks, 74 rose and 69 fell. Notable movers include RVTY (Revvity Inc) at USD 165.01 with a 1-day change of +8.81% and a typical hold time of 13 days, NBIX (Neurocrine Biosciences Inc) at USD 154.08 with a 1-day change of +6.01% and Pluang order activity showing 100% sell, and PHG (Koninklijke Philips NV) at USD 29.23 with a 1-day change of +5.94% and a typical hold time of 86 days.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
